Skip to content

PaintScape — Bruker Spatial Biology

Bruker's 3D genome visualization platform; AGBT roadmap-stage announcement with chemistry and throughput specifics not yet in public coverage.

At a glance

  • Vendor / launch date / availability: Bruker Spatial Biology; roadmap announcement at AGBT 2026 (Marco Island, Feb 22–25) per GEN AGBT 2026 recap, Feb 2026.
  • Chemistry / modality: 3D genome visualization (in-situ chromatin / nuclear architecture imaging — specific chemistry not disclosed in AGBT public coverage).
  • Throughput (PR): TBD — specific throughput numbers not surfaced in public AGBT coverage (vendor PR — no independent benchmark).
  • Resolution / plex: TBD — not surfaced in public AGBT coverage.
  • List price / reagent cost: TBD — not disclosed at AGBT.

What's new vs prior generation

PaintScape is Bruker Spatial Biology's roadmap entry into 3D genome visualization — distinct from sequencing-based Hi-C / 3C methods in that it targets in-situ spatial readout of nuclear chromatin organization. Public AGBT coverage frames it as a companion to CellScape (proteomics) in Bruker's 2026 spatial dual-track refresh, but the underlying chemistry (FISH-based chromosome painting, oligopaint, or other) is not specified in available sources — flagged as sparse.

Headline benchmarks

3D genome visualization platform — vendor PR framing only (vendor PR — no independent benchmark) — GEN AGBT 2026 recap, Feb 2026.

All quantitative specs (loci-per-cell, spatial resolution, throughput, cost) — TBD pending vendor product page and independent benchmarks.

Reception / competitive context

GenomeWeb's AGBT spatial roundup (Feb 2026) treats PaintScape and CellScape as Bruker's paired AGBT 2026 launches; PaintScape extends Bruker into the 3D-genome / chromatin-topology niche, adjacent to but distinct from sequencing-based Hi-C platforms (PacBio CiFi, Arima). Competitive set is thin in the in-situ 3D genome space — closer to academic tools (oligopaint FISH, ORCA, MERFISH-derived chromatin imaging) than to commercial sequencers.

  • Companion Bruker launch: CellScape (Bruker spatial proteomics).
  • Downstream Bioconductor stack: SpatialData, SpatialExperiment — 3D-genome readers TBD.
  • Sequencing-based 3D-genome alternative at AGBT 2026: PacBio CiFi (long-read 3C / Hi-C variant) — see launches index.
  • AACR axis: 3D genome / chromatin topology — relevant to AACR 2026 cancer-epigenomics posters; cross-vault link to be populated once AACR poster extract lands.

Sources